A circannual rhythm in rubella antibody titers

Abstract

Rubella antibody titers were assayed from 191 blood samples taken during seven years (1973–1979) from a human female who had contracted German measles in 1965. The antibody dilutions, transformed to integers, fit a first‐order harmonic function with an assumed period of 365 days. The levels about which the titers oscillated decreased from 1973 to 1975 and remained stable thereafter. Amplitudes averaged 31% on either side of the level of oscillation. At certain times of the years 1977–1979 at the trough of the rhythm the subject would have been considered to be lacking in immunity against rubella despite history to the contrary. This example of a long‐term, circannual rhythm in an immunologic assay supports previous suggestions that immunity cycles over the seasons.     

The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation

The parameters of lymphocyte, rubella virus interaction were studied by means of tritiated thymidine incorporation and compared with the rubella HIA level. Stimulation of lymphocyte DNA synthesis was found to depend on antigen concentration and to be independent of the presence of viable virus. When compared to HIA titer, lymphocyte transformation was found to be detectable in the absence of antibody. It is suggested that lymphocyte transformation is a sensitive method to detect both prior exposure and cellular immune reactivity to rubella virus.     

陕西省育龄期妇女风疹抗体水平调查

2006年在陕西省铜川、延安、宝鸡、渭南四市随机抽取20~40岁育龄期妇女共172人进行风疹IgG(RV-IgG)抗体水平调查,总阳性率87.2%,其中20~24岁组阳性率最高(95.6%),随着年龄的增长,阳性率和抗体几何平均浓度(GMC)有下降的趋势;不同居住地育龄妇女风疹抗体水平无显著性差异。这次调查反映了陕西省育龄期妇女风疹抗体水平的基本状况,为今后制定有效的免疫预防策略提供了依据。     

Surveillance of antibody to measles,mumps, and rubella by age.

Before the introduction of measles, mumps, and rubella vaccine a survey was carried out to measure antibody prevalence to the three viruses by age. A total of 8716 samples of serum collected by five public health laboratories in different parts of England during 1986-7 were tested. Despite the current measles vaccination programme 60% of children aged 1-2 years did not have measles antibody and over 80% did not have antibodies to mumps and rubella. In the 3-4 year age group 17% of the children were susceptible to measles, 55% to mumps, and 73% to rubella. The results suggest that vaccinating children early in the second year of life will be necessary to eliminate the three diseases. The survey provides baseline data for continuing surveillance of the immediate and long term effects of the new vaccination strategy.     

Surveillance of antibody to rubella virus in Grampian: closing the immunity gap.

OBJECTIVES--To identify causes for the continuing deficit of rubella immunity in women of childbearing age with a view to further reducing the risk of the congenital rubella syndrome. DESIGN--A questionnaire was sent to the general practitioner and a laboratory follow up study conducted in a one year cohort of women found on screening to have inadequate protection against rubella. SETTING--Virus laboratory of the department of medical microbiology, Aberdeen, serving the health board areas of Grampian, Orkney, and Shetland. PATIENTS--239 women whose concentration of antibodies to rubella virus was either absent or below standard (15,000 IU/l) and whose general practitioner could be contacted to supply a history of infection, immunisation, pregnancy, and antibody testing. MAIN OUTCOME MEASURES--Whether rubella vaccination was given and whether those vaccinated were tested for seroconversion. RESULTS--Only 122 (55%) of the women for whom information was available received the recommended vaccine; only 74 (61%) of these were tested for seroconversion. Oversight was the reason given for not vaccinating 64 (65%) of the women who remained at risk. Women who were pregnant when tested were significantly less likely to receive vaccine (odds ratio 3.36) than women who were not pregnant, and even if vaccinated were less likely to have a follow up antibody test (odds ratio 1.94). CONCLUSION--Once women are identified as being unprotected against rubella they are often overlooked and not vaccinated. Prompting mechanisms aimed at general practitioners, such as the one recently set up in Grampian, should reduce the immunity gap and help to eradicate rubella in pregnancy.     

The preparation of bacterial luciferase conjugates for immunoassay and application to rubella antibody detection

Bacterial luciferase has been modified with the thiolating reagent S-acetylmercaptosuccinic anhydride and covalently crosslinked to either Staphylococcus aureus protein A or anti-human immunoglobulin G (IgG) with the heterobifunctional reagent m-maleimidobenzoic acid N-hydroxysuccinimide ester. The conjugates retain enzymatic light-emitting activity and have the ability to bind IgG antibody. The ability of these conjugates to detect human IgG has been demonstrated by application to rubella immunity screening. Rubella antibodies are isolated from serum on the surface of rubella antigen-coated tubes and subsequently determined by light emitted from bound conjugate. In a preliminary study, the bioluminescent immunoassay has been compared to a commercial rubella antibody radioimmunoassay and found to be comparable in the ability to determine rubella immunity.     

The significance of specific IgM antibody in the diagnosis of rubella employing the immunofluorescence technique

The applicability of the immunofluorescence (IF) test to the diagnosis of primary rubella infection was investigated. The test is based on the detection of rubella-specific antibodies in the IgM fraction of immunoglobulins. The results indicate the usefulness of the IF test for the diagnosis of primary rubella infection on a single serum specimen collected at a proper time. The test is also of value in the differentiation of primary infection from reinfection, since in reinfection no rubella-specific antibodies are found in the IgM fraction. The test is also valuable for the detection of fetal infection in utero since the persistence of IgM antibodies in pregnant women is indicative of fetal infection.